title: How can superparamagnetic iron oxides be used to monitor disease and treatment?
authors.affiliation: ImaRx Therapeutics, 1635 E 18th St, Tucson, AZ 85719, USA. eunger@imarx.com
authors.forename: Evan C
authors.initials: EC
authors.lastname: Unger
mesh_terms: D003287:Contrast Media; D003911:Dextrans; D005290:Ferric Compounds; D052203:Ferrosoferric Oxide; D006801:Humans; D007501:Iron; D008279:Magnetic Resonance Imaging; D058185:Magnetite Nanoparticles; D010087:Oxides; D011107:Polylysine
chemical_list: D003287:Contrast Media; D003911:Dextrans; D005290:Ferric Compounds; D058185:Magnetite Nanoparticles; D010087:Oxides; C000499:ferric oxide; D011107:Polylysine; D007501:Iron; C065507:ferumoxides; D052203:Ferrosoferric Oxide